Onconetix, Inc. (ONCO): Nasdaq/NYSE listing notice — Onconetix receives second Nasdaq delisting notice for late 10-Q; hearing set May 27

Onconetix, Inc.

Received Nasdaq deficiency notice May 20 for failure to timely file Q1 2025 10-Q, adding to existing non-compliance for late 10-K.
Company also faces delisting due to bid price below $0.10 for 10 consecutive days; hearing before Nasdaq Panel scheduled May 27.
Issued $294,117.65 promissory note to Keystone Capital Partners with OID of $44,117.65; due Feb 2026 or upon equity line proceeds.
No assurance Panel will grant stay; stock delisting would follow if unfavorable decision.
Company intends to file 10-K and 10-Q as promptly as possible to regain compliance.

item 1.01 item 2.03 item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Onconetix, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

May 20, 2025, Onconetix, Inc. (the “ Company ”) received a deficiency notice (the “ Notice ”) from the Nasdaq Stock Market LLC (“ Nasdaq ”) that the Company was not in compliance with Nasdaq’s continued listing standards (the “ Listing Rules ”) as set forth in Listing Rule 5250(c)(1) given the Company’s failure to timely file its Quarterly Report on Form 10-Q for the three months ended March 31, 2025 (the “ 10-Q ”), and that this matter serves as an additional basis for delisting the Company’s securities from Nasdaq. As previously reported in the Current Report on Form 8-K filed with the Secur

View on SEC.gov

19 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Onconetix, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-046909

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.